Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Year-over-year earnings per share growth rate
Latest
112.81%
↑ 113% vs avg
Percentile
P92
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
-901.22%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 112.81% |
| Q3 2025 | 42.86% |
| Q2 2025 | 17.65% |
| Q1 2025 | 77.33% |
| Q4 2024 | 26.11% |
| Q3 2024 | -34306.78% |
| Q2 2024 | 98.10% |
| Q1 2024 | 92.79% |
| Q4 2023 | -855.56% |
| Q3 2023 | -136.84% |
| Q2 2023 | 73.24% |
| Q1 2023 | -108.82% |
| Q4 2022 | -17.24% |
| Q3 2022 | -45.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 50.00% |
| Q4 2021 | -1100.00% |
| Q3 2021 | -91.11% |
| Q2 2021 | 125.00% |
| Q1 2021 | 118.18% |
| Q4 2020 | -144.44% |
| Q3 2020 | 16.67% |
| Q2 2020 | -231.71% |
| Q1 2020 | 46.43% |
| Q4 2019 | -56.92% |
| Q3 2019 | -4.41% |
| Q2 2019 | 112.50% |
| Q1 2019 | -40.74% |
| Q4 2018 | 1.89% |
| Q3 2018 | -23.19% |
| Q2 2018 | 250.00% |
| Q1 2018 | -183.64% |
| Q4 2017 | 17.02% |
| Q3 2017 | -39.74% |
| Q2 2017 | 105.26% |
| Q1 2017 | -32.14% |
| Q4 2016 | -8.20% |
| Q3 2016 | 3.39% |
| Q2 2016 | 28.26% |
| Q1 2016 | -37.84% |